---
title: "Imunon General Counsel Susan Eylward disposes of 2,150 common shares worth $3,830.44"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293382036.md"
description: "Imunon General Counsel Susan Eylward sold 2,150 common shares on July 20 at a weighted average price of $1.78, reducing her direct holdings to 2,896 shares. The shares were acquired on July 17 via a stock grant in lieu of cash salary."
datetime: "2026-07-21T20:16:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293382036.md)
  - [en](https://longbridge.com/en/news/293382036.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293382036.md)
---

# Imunon General Counsel Susan Eylward disposes of 2,150 common shares worth $3,830.44

-   Imunon General Counsel and Corporate Secretary Susan Eylward reported a net sale of 2,150 common shares. \* Sold 2,150 shares on July 20 at a weighted average price of 1.78, cutting direct holdings to 2,896 shares. \* Acquired 2,150 shares on July 17 at 1.83 in a stock grant in lieu of cash salary. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-023948), on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IMNN.US](https://longbridge.com/en/quote/IMNN.US.md)

## Related News & Research

- [Imunon says Phase 3 OVATION 3 ovarian cancer trial enrollment outpaces plan](https://longbridge.com/en/news/294371031.md)
- [EXCLUSIVE: Imunon Outlines Accelerated Timeline, Strong Safety Data for Pivotal Ovarian Cancer Study](https://longbridge.com/en/news/294368697.md)
- [Imunon announces press release available](https://longbridge.com/en/news/293625903.md)
- [12:28 ETNNS acquires shares in OCI](https://longbridge.com/en/news/294538609.md)
- [Intuitive Surgical (NASDAQ:ISRG) EVP Sells $10,085.88 in Stock](https://longbridge.com/en/news/294272745.md)